Scott Scott Franklin
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
2 flagsThese flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $NVO | Novo Nordisk A/S Common Stock | $15K-$50K | $48.81 | — | — | Aug 4, 2025 |
| BUY | $NVO | Novo Nordisk A/S Common Stock | $1K-$15K | $48.81 | — | — | Aug 4, 2025 |
| BUY | $NVO | Novo Nordisk A/S Common Stock | $1K-$15K | $48.81 | — | — | Aug 4, 2025 |
| BUY | $NVO | Novo Nordisk A/S Common Stock | $1K-$15K | $48.81 | — | — | Aug 4, 2025 |
| SELL | $CMCSA | Comcast Corporation - Class A Common Stock | $15K-$50K | $32.56 | — | — | Aug 4, 2025 |
| SELL | $CMCSA | Comcast Corporation - Class A Common Stock | $1K-$15K | $32.56 | — | — | Aug 4, 2025 |
| SELL | $CMCSA | Comcast Corporation - Class A Common Stock | $1K-$15K | $32.56 | — | — | Aug 4, 2025 |
Connected Legislative Activity
2 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Treat and Reduce Obesity Act of 2025
The Treat and Reduce Obesity Act of 2025 would mandate Medicare Part D coverage of GLP-1 obesity drugs, unlocking a massive new payer market of ~27 million beneficiaries. $NVO and $LLY are the two direct beneficiaries. The bill is in early-stage committee referral with 22 bipartisan cosponsors; no companion bill has passed the House yet. Real market data shows $NVO gaining 15.56% over 30 days vs $LLY's +0.7%, suggesting the market may be overweighting Novo's near-term Medicare exposure given its larger U.S. obesity market share.
Lowering Broadband Costs for Consumers Act of 2025
HR4032 (Lowering Broadband Costs for Consumers Act) is an early-stage bill that would expand USF contribution requirements to broadband and edge providers. It remains in committee with no floor action, making near-term market impact negligible. If passed, $CMCSA, $T, $VZ, $GOOGL, $META, $AMZN, and $NFLX would face new recurring costs reducing segment margins by an estimated 1-3%.
Other Filings by Scott Scott Franklin
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.